A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-Like 1 hexapeptide ligand

Cytometry Part A

Volumn 75, Issue 3, 2009, Pages 264-270

  Strouse, J Jacob ^a   Young, Susan M ^a   Mitchell, Hugh D ^b   Ye, Richard D ^c   Prossnitz, Eric R ^b   Sklar, Larry A ^a,b   Edwards, Bruce S ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cross reactive; Flow cytometry; Fluorescent ligand; Formylpeptide receptor; Formylpeptide receptor like 1; FPR; FPRL1; GPCR; W peptide; WKYMVm

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS REACTION; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CHEMOTACTIC FACTORS; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; HUMANS; LIGANDS; OLIGOPEPTIDES; PEPTIDES; RATS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; TRANSFECTION; U937 CELLS;

EID: 65349145196     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20670     Document Type: Article

References (40)

1. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23:541-548.
2. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene \"intercrine\" cytokine family. Annu Rev Immunol 1991;9:617-648.
3. Keitoku M, Kohzuki M, Katoh H, Funakoshi M, Suzuki S, Takeuchi M, Karibe A, Horiguchi S, Watanabe J, Satoh S, Nose M, Abe K, Okayama H, Shirato K. FMLP actions and its binding sites in isolated human coronary arteries. J Mol Cell Cardiol 1997;29:881-894.
4. Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astro- cytes and microglia. J Neuroimmunol 1995;61:71-78.
5. McCoy R, Haviland DL, Molmenti EP, Ziambaras T, Wetsel RA, Perlmutter DH. N- formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med 1995;182:207-217.
6. Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, Van Damme J, Vali- tutti S, Lanzavecchia A, Mantovani A. Migration of dendritic cells in response to for- myl peptides, C5a, and a distinct set of chemokines. J Immunol 1995;155:3292-3295.
7. Bao L, Gerard NP, Eddy RL Jr, Shows TB, Gerard C. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homolog orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 1992;13:437-40.
8. Prossnitz ER, Ye RD. The N-formyl peptide receptor: A model for the study of che- moattractantreceptorstructureand function. Pharmacol Ther1997;74:73-102.
9. Gronert K, Gewirtz A, Madara JL, Serhan CN. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon g and inhibits tumor necrosis factor a-induced IL-8 release. J Exp Med 1998;187:1285-1294.
10. Le Y, Hu J, Gong W, Shen W, Li B, Dunlop NM, Halverson DO, Blair DG, Wang JM. Expression of functional formyl peptide receptors by human astrocytoma cell lines. J Neuroimmunol2000;111:102-108.
11. Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun 1992;184:582-589.
12. VanCompernolle SE, Clark KL, Rummel KA, Todd SC. Expression and function of formyl peptide receptors on human fibroblast cells. J Immunol 2003;171:2050-2056.
13. Le Y, Wang JM, Liu X, Kong Y, Hou X, Ruan L, Mou H. Biologically active peptides interacting with the G protein-coupled formylpeptide receptors. Protein Pept Lett 2007;14:846-853.
14. Rabiet M-J, Huet E, Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes- derived peptides preferentially activate FPR. Eur J Immunol 2005;35:2486-2495.
15. Derian CK, Solomon HF, Higgins JD III, Beblavy MJ, Santulli RJ, Bridger GJ, Pike MC, Kroon DJ, Fischman AJ. Selective inhibition of N-formylpeptide- induced neu- trophil activation by carbamate-modified peptide analogs. Biochemistry 1996;35:1265-1269.
16. Gao JL, Becker EL, Freer RJ, Muthukumaraswamy N, Murphy PM. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J Exp Med 1994;180:2191-2197.
17. Higgins JD III, Bridger GJ, Derian CK, Beblavy MJ, Hernandez PE, Gaul FE, Abrams MJ, Pike MC, Solomon HF. N-terminus urea-substituted chemotactic peptides: New potent agonists and antagonists toward the neutrophil fMLF receptor. J Med Chem 1996;39:1013-1015.
18. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cyto-kine Growth Factor Rev2001;12:91-105.
19. He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein- coupled receptor, FPRL1/LXA4R. Blood 2003;101:1572-1581.
20. Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao J-L, Murphy PM, Oppenheim JJ, Wang JM. Amyloid b42 activates a G-protein- coupledchemoattractantreceptor,FPR-like-1. JNeurosci2001;21:RC123/1-RC123/ 5.
21. Le Y, Yazawa H, Gong W, Yu Z, Ferrans VJ, Murphy PM, Wang JM. Cutting edge: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J Immunol 2001;166: 1448-1451.
22. Snipe JD. The acute phase response. In: Shevac EM, editor. Immunophysiology: The Role of Cells and Cytokines in Immunity and Inflammation. New York: Oxford University Press; 1990. pp 259-273.
23. Kalaria RN. Microglia and Alzheimer's disease. Curr Opin Hematol 1999;6:15-24.
24. Le Y, Yang Y, Cui Y, Yazawa H, Gong W, Qiu C, Wang JM. Receptors for chemotac- tic formyl peptides as pharmacological targets. Int J Immunopharmacol 2002;2:1-13.
25. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizesformylpeptidereceptor-like1 (FPRL1) asareceptortochemoattracthuman peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
26. Le Y, Jiang S, Hu J, Gong W, Su S, Dunlop NM, Shen W, Li B, Wang JM. N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes. Clin Immunol 2000;96:236-242.
27. Baek SH, Seo JK, Chae C-B, Suh P-G, Ryu SH. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J BiolChem 1996;271:8170-8175.
28. Bae Y-S, Song JY, Kim Y, He R, Ye RD, Kwak J-Y, Suh P-G, Ryu SH. Differential activation of formyl peptide receptor signaling by peptide ligands. Mol Pharmacol 2003;64:841-847.
29. Kuckuck FW, Edwards BS, Sklar LA. High throughput flow cytometry. Cytometry 2001;44:83-90.
30. Ramirez S, Aiken Charity T, Andrzejewski B, Sklar Larry A, Edwards Bruce S. High- throughput flow cytometry: Validation in microvolume bioassays. Cytometry Part A 2003;53A:55-65.
31. Prossnitz ER. Desensitization of N-formylpeptide receptor-mediated activation is dependent upon receptor phosphorylation. J Biol Chem 1997;272:15213-15219.
32. Young SM, Bologa CM, Fara D, Bryant BK, Strouse JJ, Arterburn JB, Ye RD, Oprea TI, Prossnitz ER, Sklar LA, Edwards BS. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes. Cytometry Part A 2008; early view.
33. Fay SP, Posner RG, Swann WN, Sklar LA. Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry. Biochemistry 1991;30:5066-5075.
34. Prossnitz ER. Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors. Life Sci 2004;75:893-899.
35. Vines CM, Revankar CM, Maestas DC, LaRusch LL, Cimino DF, Kohout TA, Lefko-witz RJ, Prossnitz ER. N-Formyl peptide receptors internalize but do not recycle in the absence of arrestins. J Biol Chem 2003;278:41581-41584.
36. Huet E, Boulay F, Barral S, Rabiet M-J. The role of b-arrestins in the formyl peptide receptor-like 1 internalization and signaling. Cell Signal2007;19:1939-1948.
37. Seo JK, Choi S-Y, Kim Y, Baek SH, Kim K-T, Chae C-B, Lambeth JD, Suh P-G, Ryu SH. A peptide with unique receptor specificity. J Immunol 1997;158:1895-1901.
38. Wan H-X, Zhou C, Zhang Y, Sun M, Wang X, Yu H, Yang X, Ye RD, Shen J-K, Wang M-W. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide re-ceptor-like1. BiochemPharmacol2007;74:317-326.
39. Edwards BS, Young SM, Oprea TI, Bologa CG, Prossnitz ER, Sklar LA. Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-through put flow cytometry platform. Nat Protocol 2006;1:59-66.
40. Bae Y-S, Yi HJ, Lee H-Y, Jo EJ, Kim JI, Lee TG, Ye RD, Kwak J-Y, Ryu SH. Differential activation of formyl peptide receptor-like 1 by peptide ligands. J Immunol 2003;171:6807-6813.